Gamma-glutamyltransferase predicts macrovesicular liver graft steatosis – an analysis of discarded liver allografts in Finland
- 28 October 2022
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (4) , 412-416
Abstract
Objective: Liver-transplantation activity is limited by the shortage of grafts. Donor-liver macrovesicular steatosis predisposes to ischemia-reperfusion injury and is associated with reduced graft survival. The increasing prevalence of fatty-liver disease underlines the importance of identifying macrovesicular steatosis in potential donor livers. We analyzed liver grafts discarded for transplantation, and particularly the role of gamma-glutamyltransferase (GGT) in predicting graft steatosis. Methods: One-hundred sixty rejected cadaveric-donor liver grafts were studied. Donor selection was based on clinical data, and macroscopic graft inspection. Discarded grafts were biopsied at procurement of non-liver organs. Results: The most common reasons for discarding the graft were abnormal liver tests, ultrasound-verified steatosis and history of harmful alcohol use. GGT correlated moderately with macrovesicular steatosis (r = 0.52, p < 0.001), but poorly with microvesicular steatosis (r = 0.36, p < 0.001). Increased correlation between GGT and macrovesicular steatosis was observed among alcohol abusers (r = 0.67, p < 0.001). Area under the curve (AUC) of GGT for predicting >30% macrovesicular steatosis was 0.79 (95% CI 0.71–0.88), and for >60% steatosis, 0.79 (95% CI 0.68–0.90). The optimal GGT-cut off for detecting >30% and >60% macrovesicular steatosis were, respectively, 66 U/L (sensitivity 76% and specificity 68%) and 142 U/L (sensitivity 66% and specificity 83%). Among alcohol users, a GGT value >90 U/L showed 100% sensitivity for >60% macrovesicular steatosis. AUC for GGT in predicting fibrosis Stages 2–4 was 0.82 (95% CI 0.71–0.92, p < 0.001, optimal cut off 68, sensitivity 92%, specificity 61%). Conclusions: Abnormal liver values, steatosis and harmful alcohol use were the main reasons for discarding liver-graft offers in Finland. GGT proved useful in predicting moderate and severe liver graft macrovesicular steatosis.Keywords
This publication has 29 references indexed in Scilit:
- Assessment of hepatic steatosis by transplant surgeon and expert pathologist: A prospective, double-blind evaluation of 201 donor liversLiver Transplantation, 2013
- The Eurotransplant Donor Risk Index in Liver Transplantation: ET-DRIAmerican Journal of Transplantation, 2012
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohortJournal of Hepatology, 2012
- Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk IndexJournal of Gastroenterology and Hepatology, 2011
- The Biopsied Donor Liver: Incorporating Macrosteatosis Into High-Risk Donor AssessmentLiver Transplantation, 2010
- Use of Severely Steatotic Grafts in Liver TransplantationAnnals of Surgery, 2007
- Influence of Degree of Hepatic Steatosis on Graft Function and Postoperative Complications of Liver TransplantationTransplantation Proceedings, 2006
- Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk IndexAmerican Journal of Transplantation, 2006
- Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular riskDiabetologia, 2004
- Gamma Glutamyl TransferaseCritical Reviews in Clinical Laboratory Sciences, 2001